Related Experiment Video
Updated: Jun 7, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Metastasis development in non-muscle-invasive bladder cancer
Michael Leyderman1, Thenappan Chandrasekar2, Petros Grivas3
1Department of Urology, SUNY Upstate Medical University, Syracuse, NY, USA.
Metastatic non-muscle-invasive bladder cancer (NMIBC) is rare but can occur without evidence of muscle invasion. This perspective explores potential causes like understaging and circulating tumor cells.
Area of Science:
- Uro-oncology
- Cancer Metastasis Research
Background:
- Non-muscle-invasive bladder cancer (NMIBC) is the most frequent bladder cancer diagnosis.
- NMIBC typically has a variable risk of recurrence and progression.
- Rarely, NMIBC can metastasize despite no pathological muscle-invasive disease in the bladder.
Purpose of the Study:
- To consolidate and present existing data on metastatic NMIBC.
- To investigate potential etiological factors contributing to this rare condition.
Main Methods:
- Literature review and data integration.
- Analysis of case reports and small reviews on metastatic NMIBC.
- Exploration of potential contributing factors.
Main Results:
- Metastatic NMIBC is an infrequently documented phenomenon.
- Several factors are hypothesized to be associated with metastatic NMIBC.
- Potential factors include tumor understaging, prior transurethral resection procedures, circulating tumor cells, diagnostic cystoscopy methods, and gender differences.
Conclusions:
- Metastatic NMIBC requires further investigation due to limited available data.
- Understanding the etiology of metastatic NMIBC is crucial for patient management.
- Further research is needed to elucidate the mechanisms behind metastasis in NMIBC.
More Related Videos
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia